ClinicalTrials.govpublic full text
A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations
solid tumor, adult, intrahepatic cholangiocarcinoma, urothelial carcinoma, fgfr inhibitor, targeted therapy, fgfr2 alteration, fgfr3 alteration, secondary resistance, fgfr alteration, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 851012
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.